See also this year's filing and all EDGAR filings for this company.
PDF Report 0001418133_2016_Biostar_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001418133, Biostar Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 16,167,309 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 6,878,787 |
| 2 | PropertyPlantAndEquipmentNet | 6,810,933 |
| 3 | remainder_Assets | 21,506,551 |
| 4 | LiabilitiesCurrent | 7,098,441 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 16,025,544 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,648,902 |
| 9 | ResearchAndDevelopmentExpense | 4,020,909 |
| 10 | remainder_Expenses | 27,511,664 |
| 11 | remainder_Revenues | 27,129,609 |
| 12 | remainder_NetIncome | -35,152 |
| 13 | remainder_ComprehensiveNetIncome | -2,957,650 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 51,363,580 |
| 1 | Liabilities | 7,098,441 |
| 2 | Expenses | 52,207,019 |
| 3 | Revenues | 27,129,609 |
| 4 | StockholdersEquity | 44,265,139 |
| 5 | NetIncome | -25,112,562 |
| 6 | ComprehensiveNetIncome | -26,591,387 |
| 7 | BaseVar | 70,395,726 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.39 |
| 9 | EconomicCapitalRatio | 3.28 |
Edgar->Model Mapping
Feature Distribution
Change over Time
